Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

168 Press Releases
DateTitleCompany
09 Jan 14 Isarna Therapeutics Enters into a Strategic Manufacturing Agreement with Sanofi Isarna Therapeutics,
Published by
PharmiWeb.com
09 Jan 14 Daclatasvir Marketing Authorisation Application for Treatment of Chronic Hepatitis C Validated for Accelerated Regulatory Review by the European Medicines Agency Bristol-Myers Squibb
09 Jan 14 Clinigen Group to Provide VIBATIV® to Patients with Hospital-Acquired Bacterial Pneumonia in Europe via Access Program The Clinigen Group
09 Jan 14 Apitope Led Consortium Receives up to €6M FP7 Funding to Develop Novel Therapeutic Vaccine for Graves’ Disease Apitope
08 Jan 14 Isarna Therapeutics Raises Euro 13 Million from New and Current Investors Isarna Therapeutics
06 Jan 14 Science Warehouse signs Ireland’s Number 1 Science Warehouse
03 Jan 14 Star's support team beats 6 other finalists to win 'Best Back Office Support Team' 2013 at REC's IRP awards Star
03 Jan 14 Sanofi To Expand Access to Clinical Trial Data Sanofi
02 Jan 14 Noted Surgical Gastroenterologist & Global Hospitals Founder Dr. Kancherla Ravindranath crowned at 6th Annual Pharmaceutical Leadership Summit & Awards 2013 pharmaleaders,
Published by
http://breakfastnews.tv/
23 Dec 13 Actelion’s Opsumit®? (macitentan) granted European Marketing Authorisation for the long-term treatment of adult patients with Pulmonary Arterial Hypertension (PAH) Actelion Pharmaceuticals UK,
Published by
Packer Forbes Communications
23 Dec 13 BIT’s 7th Annual World Congress of Regenerative Medicine & Stem Cells-2014 BIT Congress Inc.
20 Dec 13 ARGX-110, a novel anti-CD70 antibody, meets translational development goals in dose escalation part of Phase Ib cancer study arGEN-X,
Published by
Citigate Dewe Rogerson
20 Dec 13 Bone Therapeutics and partners awarded highly competitive €3.8 million Marie Curie research grant Bone Therapeutics SA
20 Dec 13 John van der Valk appointed MD of UBM Live Amsterdam CPhI,
Published by
De Facto Communications
19 Dec 13 Sanofi and Regeneron Announce Collaboration with American College of Cardiology for PCSK9 Inhibitor Clinical Program Sanofi
18 Dec 13 All Wales Medicines Strategy Group recommends Onglyza® (saxagliptin) for use in triple therapy for type 2 diabetes patients Bristol-Myers Squibb and AstraZeneca,
Published by
Packer Forbes Communications
18 Dec 13 Computer-controlled table could direct radiotherapy to tumours The Institute of Cancer Research
18 Dec 13 ABPI response to GSK announcement regarding changes to its global sales and marketing practice ABPI
18 Dec 13 UKCPA welcomes Scottish government’s vision for pharmaceutical care UKCPA
18 Dec 13 Centro Ricerche Cliniche di Verona Receives First Ever EUCROF Early Phase Unit Quality Mark CROMSOURCE
16 Dec 13 New Speakers Announced for the 4th Annual Traumatic Brain Injury Conference Arrowhead Publishers
16 Dec 13 All Wales Medicines Strategy Group recommends Onglyza® (saxagliptin) for use in triple therapy for type 2 diabetes patients Bristol-Myers Squibb and AstraZeneca,
Published by
Packer Forbes Communications
16 Dec 13 Recipharm subsidiary files infectious disease drug application in European markets RPH Pharmaceuticals AB,
Published by
DeFacto Communications
16 Dec 13 AstraZeneca announces top-line results from phase III monotherapy study of lesinurad in gout patients AstraZeneca
13 Dec 13 GILEAD ANNOUNCES INTERIM PHASE 2 RESULTS FOR GS-9973 IN PREVIOUSLY TREATED CHRONIC LYMPHOCYTIC LEUKEMIA Gilead Sciences, Inc,
Published by
Gilead Sciences
13 Dec 13 GILEAD ANNOUNCES PIVOTAL PHASE 2 DATA FOR IDELALISIB IN REFRACTORY INDOLENT NON-HODGKIN’S LYMPHOMA Gilead Sciences, Inc.,
Published by
Gilead Sciences
12 Dec 13 CPhI Japan 2014: Japanese market to continue to dominate global pharma CPhI,
Published by
DeFacto Communications
12 Dec 13 Bridgepoint Development Capital to acquire Quotient Clinical Quotient Clinical,
Published by
Bridgepoint
11 Dec 13 Senior-Level Pharmaceutical Experts, Keynotes from Pharma VP, Trends & Analytics Guru- All at ‘Super Bowl’ of Pharma Biotech Conferences Pharma Market Research Conference
11 Dec 13 Pharmaceutical, Biotechnology, Healthcare Experts to Converge at Crucial Event in 2014 Pharma CI Conference
Advertising